EBI Consulting recently provided Environmental Health and Safety (EHS) services to a new company in Cambridge, Massachusetts called Fulcrum Therapeutics.
Fulcrum Therapeutics, is a biotechnology company that is dedicated to developing new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. They are working towards finding new ways to give those living with genetic diseases, a better tomorrow.
Fulcrum Therapeutics shared an inspiring story from the National Fragile X Foundation about a girl named Kelley Devine who has Fragile X Syndrome. According to the U.S. National Library of Medicine, Fragile X Syndrome is a genetic condition that causes a range of developmental problems like learning disabilities and cognitive impairment and studies show males are affected more severely than females (U.S. National Library of Medicine).  Kelley wrote the story herself and explains the struggle she went through growing up and understanding Fragile X Syndrome. In 2010, Kelley attended a conference that supported others who have Fragile X Syndrome. She made lots of friends and that experience helped her change her life. Kelley is now a college graduate from Bridgewater State University and she recently obtained a job within the court system. Read more of Kelley’s story here.
Our team of Environmental Health and Safety professionals were able to assist Fulcrum Therapeutics with laboratory commissioning, administering new hire training, laboratory safety training, obtaining all the necessary permits for laboratory operations and developing OSHA compliance programs. Professionals from both EBI Consulting and Fulcrum Therapeutics, worked together to ensure their laboratories were properly set up to comply with local, state and federal regulatory agencies. In addition to those services, EBI’s wastewater experts were able to assist Fulcrum in obtaining a MWRA Sewer Use Discharge Permit, preparing an Operations & Maintenance manual, and commissioning Fulcrum’s industrial pretreatment system for pH neutralization.
Fulcrum Therapeutics is dedicated to helping those like Kelley, live a better life. EBI Consulting is proud to provide services to companies like Fulcrum Therapeutics. To read more about Fulcrum Therapeutics, please visit their website. If you are interested in learning more about our EHS services, please read more about them here or contact one of our EHS professionals!
About Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum’s therapies are based on modulating gene regulation via control of genetic on and off switches of disease genes. Fulcrum was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information please visit www.fulcrumtx.com
FULCRUM CONTACTS:
Media:
Dan Quinn, Ten Bridge Communications
781-475-7974
